Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $272,216 - $304,654
1,400 New
1,400 $274,000
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $4.99 Million - $6.76 Million
26,000 New
26,000 $5.25 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $18,244 - $25,054
100 New
100 $20,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $20,413 - $30,239
-100 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $2.53 Million - $3.58 Million
-9,900 Reduced 99.0%
100 $28,000
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $3.54 Million - $4.35 Million
9,500 Added 1900.0%
10,000 $4.13 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $33.7 Million - $38.3 Million
-151,600 Reduced 99.67%
500 $125,000
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $26.7 Million - $34.4 Million
152,100 New
152,100 $34.4 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.